Latest
Structure Search
Popular Resources
Events & Community
Directories
Quick Search
Ctrl+
K
PREMIUM
NEUROLOGY
IMMUNOLOGY
5 minute read
Feb. 12, 2022
Daridorexant, Abrocitinib, Tebentafusp, and Faricimab Among Drug Approvals in Jan. 2022
Drug Hunter Team
Reviewer:
Jennifer Huen
Loading...
Other articles you may be interested in